Cortexyme
$40.709876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$40.70
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$5.77 (+16.52%) As of 3:47 PM EDT today
+$5.77 (+16.52%) Today
Why Robinhood?
You can buy or sell Cortexyme and other stocks, options, ETFs, and crypto commission-free!
About CRTX
Cortexyme, Inc. Common Stock, also called Cortexyme, is a biopharmaceutical company, which develops therapeutics based on data supporting a new theory of the cause of Alzheimer's and other neurodegenerative disorders. Read More Its product, COR388, is in clinical trial. The company was founded by Casey Crawford Lynch, Stephen Dominy, and Kristen Gafric on June 20, 2012 and is headquartered in South San Francisco, CA.
Employees
23
Headquarters
South San Francisco, California
Founded
2012
Market Cap
1.16B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
139.38K
High Today
$42.19
Low Today
$35.78
Open Price
$36.65
Volume
166.59K
52 Week High
$73.84
52 Week Low
$19.35
Collections
CRTX Earnings
-$0.57
-$0.38
-$0.19
$0.00
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
—